Legal Affairs
Helus Pharma Advances Phase 3 Trial for Novel Therapy in MDD
NEW YORK – Helus Pharma, the business name now used by Cybin Inc., announced that enrollment in its APPROACH Phase 3 trial has passed the 86% mark. The trial is testing HLP003, the company's lead ...
Hemp THC Beverages Return to Ohio Shelves
CLEVELAND – Hemp-derived THC drinks are back on a limited number of Ohio shelves after U.S. District Judge Jeffrey Helmick temporarily blocked the state from enforcing its newest hemp licensing law against a group of ...
Georgia Expands Access to Medical Cannabis
ATLANTA – A revised medical Cannabis law takes effect in Georgia on Wednesday, broadening the conditions that qualify patients for legal access and permitting vaporization as an approved method of use for the first time. ...
Trulieve Approved to Uplist to NYSE in Historic Milestone for U.S. Cannabis Industry
TALLAHASSEE, Fla. — June 5, 2026 — In a landmark moment for the U.S. Cannabis industry, Trulieve Cannabis Corp. announced today that it has received approval to list its subordinate voting shares on the New ...
Psilocybin Shows Promise in Treating Cocaine Addiction
BIRMINGHAM – For the first time, a peer-reviewed, randomized clinical trial showed that psilocybin significantly reduced cocaine use when combined with structured psychotherapy. The findings, published in JAMA Network Open by researchers at the University ...
Lawmakers Press IRS for Clear Tax Rules on State-Legal Cannabis Operations
WASHINGTON – Rep. Steven Horsford (D) and Rep. Steve Cohen (D) led a letter to Treasury Secretary Scott Bessent and IRS Chief Executive Officer Frank Bisignano, urging the administration to provide clear, timely guidance for ...
FundCanna Launches Free Dispensary Inventory Calculator
SAN DIEGO – Cash flow has always been the structural fault line running beneath Cannabis retail. Operators juggle compressed margins, limited banking access, and pricing pressure from a market that hasn't stopped softening. Yet, one ...
Helus Pharma Advances Phase 3 Trial for Novel Therapy in MDD
NEW YORK – Helus Pharma, the business name now used by Cybin Inc., announced that enrollment in its APPROACH Phase 3 trial has passed the 86% mark. The trial is testing HLP003, the company's lead ...
Hemp THC Beverages Return to Ohio Shelves
CLEVELAND – Hemp-derived THC drinks are back on a limited number of Ohio shelves after U.S. District Judge Jeffrey Helmick temporarily blocked the state from enforcing its newest hemp licensing law against a group of ...
Georgia Expands Access to Medical Cannabis
ATLANTA – A revised medical Cannabis law takes effect in Georgia on Wednesday, broadening the conditions that qualify patients for legal access and permitting vaporization as an approved method of use for the first time. ...
Why Bob Hoban Is Defending Steve DeAngelo—And What It Reveals About Cannabis Policy
LOS ANGELES- In cannabis industry discourse, facts can be overshadowed by simplified narratives. One such claim—widely circulated in trade circles—is that Steve DeAngelo, founder of Harborside and a prominent figure in the legalization movement, was ...
DEA Grants Import Permit for Psilocybin Truffles to Red Light Holland and Irvine Labs
LOS ANGELES- Red Light Holland Corp, an Ontario-based producer of psilocybin truffles, announced that its U.S. partner, Irvine Labs, has received a Controlled Substances Import Permit from the Drug Enforcement Administration (DEA). This authorization allows ...
Glass House Brands Proposes Long-Term Incentive Plan Tied to Share Price Performance
LOS ANGELES- Glass House Brands Inc. a vertically integrated cannabis company, has announced the mailing of its management information circular to shareholders ahead of its annual and special meeting scheduled for June 20, 2025. At ...
Minnesota Legislature Advances Cannabis Market Framework to Governor
LOS ANGELES- Minnesota lawmakers have passed a comprehensive bill aimed at refining the state's adult-use cannabis program, forwarding it to Governor Tim Walz for approval. The legislation, known as SF 2370, seeks to address regulatory ...
Cannabis in Psychedelic Therapy: Potential and Precautions
LOS ANGELES- The integration of cannabis into psychedelic-assisted psychotherapy is gaining attention as a potential treatment for various mental health conditions, including post-traumatic stress disorder (PTSD), depression, and anxiety. This approach involves administering cannabis in ...
Cybin Partners with Thermo Fisher for U.S. Manufacturing
LOS ANGELES- Cybin Inc. a neuropsychiatry company, has announced a collaboration with Thermo Fisher Scientific to support the Phase 3 clinical supply and potential commercial manufacturing of CYB003, its proprietary deuterated psilocin analog, for the ...
Rubicon Organics Appoints Glen Ibbott as Interim CFO
LOS ANGELES- Rubicon Organics Inc. a Canadian producer of certified organic cannabis products, has appointed Glen Ibbott as Interim Chief Financial Officer, effective May 15, 2025. This leadership change follows the departure of Janis Risbin ...
TILT Holdings Reports First Quarter 2025 Financial Results
LOS ANGELES- TILT Holdings Inc. announced its financial results for the first quarter ended March 31, 2025, reflecting a year-over-year revenue decline and continued strategic realignment towards its Jupiter inhalation technology business. Financial Performance The ...
High-Paying Roles in the Cannabis Industry
LOS ANGELES- As the cannabis industry continues its expansion across the United States, it presents a variety of high-paying career opportunities. Positions such as cultivation directors, compliance officers, and extraction technicians are in demand, offering ...
German Medical Cannabis Market Sees Significant Growth
LOS ANGELES- Germany's medical cannabis industry is experiencing substantial growth, driven by recent regulatory reforms and increasing patient demand. Companies such as Cantourage are at the forefront of this expansion, capitalizing on the evolving legal ...
Canopy Growth Introduces Targeted Product Expansion for Canadian Market
LOS ANGELES- Canopy Growth Corporation has announced a strategic expansion of its product portfolio, focusing on four high-demand segments within Canada's adult-use cannabis market: vapes, high-THC flower, pre-rolls, and edibles. This initiative is part of ...
U.S. Legal Cannabis Sales Surpass $30 Billion in 2024
LOS ANGELES- In 2024, legal cannabis sales in the United States reached $30.1 billion, marking a 4.5% increase from the previous year. This growth occurred despite a 3.4% reduction in industry employment, equating to approximately ...
iAnthus Capital Holdings Reports Q1 2025 Financial Results
LOS ANGELES- iAnthus Capital Holdings, Inc. a multi-state operator in the U.S. regulated cannabis industry, released its financial results for the first quarter ended March 31, 2025. Financial Highlights Revenue: $38.1 million, a decrease from ...
Silo Pharma Initiates Safety Study for PTSD Drug SPC-15
LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, has commenced a 7-day safety and toxicology study for its lead candidate, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD). The study is being conducted ...
Glass House Brands to Manage The Leaf El Paseo Dispensary
LOS ANGELES- Glass House Brands Inc. and LEEF Brands Inc. have entered into a Management Services Agreement (MSA), under which Glass House will oversee operations of The Leaf El Paseo dispensary in Palm Desert, California. ...
Pennsylvania Senate Committee Rejects Cannabis Legalization Bill
LOS ANGELES- In a recent development, the Pennsylvania Senate Law and Justice Committee voted 7-3 against House Bill 1200, a proposal aimed at legalizing adult-use cannabis in the state. This decision follows the bill's narrow ...
Humboldt Family Farms: The Science of Natural Light
In the lush tapestry of cannabis cultivation, the sun shines like a master artist, painting each plant with strokes of light that define its essence. The embrace of natural sunlight not only stimulates the growth ...
atai Life Sciences Initiates Phase 2 Trial of EMP-01 for Social Anxiety Disorder
LOS ANGELES- atai Life Sciences has commenced a Phase 2 clinical trial evaluating EMP-01, an oral formulation of R-3,4-methylenedioxy-methamphetamine (R-MDMA), for the treatment of social anxiety disorder (SAD). The first patient has been dosed in ...
Village Farms International Reports Q1 2025
LOS ANGELES- Village Farms International Inc. has announced its financial results for the first quarter of 2025, highlighting a strategic pivot towards its cannabis operations and the privatization of certain fresh produce assets. For the ...
Legalization Significantly Reduces Canada’s Illicit Cannabis Market
LOS ANGELES- Recent analyses indicate that Canada's legalization of non-medical cannabis in 2018 has substantially shifted consumer spending from illicit to legal markets. Studies report that within five years of legalization, approximately 75% of cannabis ...
New York Cannabis Policy Faces Criticism Amid Regulatory Challenges
LOS ANGELES- Boris Jordan, CEO of Curaleaf Holdings Inc., a multi-state cannabis operator, has publicly criticized New York Governor Kathy Hochul and state cannabis regulators, alleging that current policies are detrimental to established medical cannabis ...
Cybin Secures Additional U.S. Patent for CYB003
LOS ANGELES- Cybin Inc. a biopharmaceutical company, announced the granting of U.S. patent 12,291,499 by the United States Patent and Trademark Office. This patent pertains to pharmaceutical compositions and oral dosage forms within the company's ...
Green Thumb Industries Reports Q1 2025 Financial Results
Green Thumb Industries Inc. a U.S.-based cannabis consumer packaged goods company and owner of RISE Dispensaries, announced its financial results for the first quarter ended March 31, 2025. Financial Highlights Revenue for Q1 2025 was ...
Pennsylvania House Approves State-Run Recreational Cannabis Bill
LOS ANGELES- The Pennsylvania House of Representatives has passed a bill to legalize recreational cannabis, proposing a state-controlled sales model. The legislation, approved by a narrow 102-101 vote along party lines, marks the first time ...
Boston Beer Company Expands Cannabis Beverage Portfolio
LOS ANGELES- The Boston Beer Company, through its Canadian subsidiary BBCCC Inc., has announced the expansion of its cannabis-infused beverage offerings for the summer season. The company introduced a new TeaPot Rosin-Infused Lemon Black Iced ...
